Dendritic Cell Therapy in Transplantation, Phenotype Governs Destination and Function.
作者信息
Samy Kannan P, Brennan Todd V
机构信息
Department of Surgery, Indiana University School of Medicine, IN.
Department of Surgery, Duke University School of Medicine, Durham, NC.
出版信息
Transplantation. 2018 Oct;102(10):1593-1594. doi: 10.1097/TP.0000000000002238.
Abstract
摘要
相似文献
1
Dendritic Cell Therapy in Transplantation, Phenotype Governs Destination and Function.
Transplantation. 2018 Oct;102(10):1593-1594. doi: 10.1097/TP.0000000000002238.
2
Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1353-60; discussion 1360-1. doi: 10.1016/j.jtcvs.2006.09.124.
3
[Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?].
Ugeskr Laeger. 2007 Sep 24;169(39):3287-9.
4
Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.
Curr Opin Organ Transplant. 2011 Aug;16(4):372-8. doi: 10.1097/MOT.0b013e3283484b42.
5
Dendritic cell TH2 cytokine gene therapy in sheep.
Transplant Proc. 2001 Feb-Mar;33(1-2):180-1. doi: 10.1016/s0041-1345(00)01965-5.
6
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA.
Transplant Proc. 2001 Feb-Mar;33(1-2):235. doi: 10.1016/s0041-1345(00)01991-6.
7
Destination therapy--time for a paradigm change in heart failure therapy.
Swiss Med Wkly. 2013 Mar 25;143:w13729. doi: 10.4414/smw.2013.13729. eCollection 2013.
8
Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells.
Transplantation. 2003 Apr 27;75(8):1160-5. doi: 10.1097/01.TP.0000061792.78914.52.
9
[Dendritic cells and transplantation immune tolerance--review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):849-52.
10
Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2016 Feb 8;16(3):1-60. eCollection 2016.
引用本文的文献
1
Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.
Vaccines (Basel). 2021 May 20;9(5):535. doi: 10.3390/vaccines9050535.
本文引用的文献
1
State of the Art: Role of the Dendritic Cell in Induction of Allograft Tolerance.
Transplantation. 2018 Oct;102(10):1603-1613. doi: 10.1097/TP.0000000000002239.
2
Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.
Front Immunol. 2017 Dec 11;8:1764. doi: 10.3389/fimmu.2017.01764. eCollection 2017.
3
Comparative Study of the Immunoregulatory Capacity of In Vitro Generated Tolerogenic Dendritic Cells, Suppressor Macrophages, and Myeloid-Derived Suppressor Cells.
Transplantation. 2016 Oct;100(10):2079-2089. doi: 10.1097/TP.0000000000001315.
4
Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms.
Front Immunol. 2016 Mar 7;7:87. doi: 10.3389/fimmu.2016.00087. eCollection 2016.
5
Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance.
J Immunol. 2014 Nov 1;193(9):4696-703. doi: 10.4049/jimmunol.1401423. Epub 2014 Sep 24.
6
Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.
Am J Transplant. 2014 May;14(5):1021-1031. doi: 10.1111/ajt.12708. Epub 2014 Apr 14.
7
Tolerogenic dendritic cells and their role in transplantation.
Semin Immunol. 2011 Aug;23(4):252-63. doi: 10.1016/j.smim.2011.06.007. Epub 2011 Jul 7.
8
Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.
Transpl Immunol. 2009 Sep;21(4):203-9. doi: 10.1016/j.trim.2009.05.003. Epub 2009 May 14.
9
Preferential priming of alloreactive T cells with indirect reactivity.
Am J Transplant. 2009 Apr;9(4):709-18. doi: 10.1111/j.1600-6143.2009.02578.x.
10
Human dendritic cells and transplant outcome.
Transplantation. 2008 Jun 15;85(11):1513-22. doi: 10.1097/TP.0b013e318173a768.
Zotero 插件